お知らせ • May 27
Les Hôtels de Paris SA, Annual General Meeting, Jun 30, 2026 Les Hôtels de Paris SA, Annual General Meeting, Jun 30, 2026. Location: normandy hotel 7 rue de l echelle, paris France New Risk • Apr 19
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-€54m). Earnings have declined by 7.2% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Market cap is less than US$100m (€14.9m market cap, or US$17.6m). New Risk • Oct 03
New major risk - Revenue and earnings growth Earnings have declined by 4.0% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-€47m). Earnings have declined by 4.0% per year over the past 5 years. Minor Risk Market cap is less than US$100m (€15.5m market cap, or US$18.2m). New Risk • Sep 11
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Negative equity (-€47m). Minor Risk Market cap is less than US$100m (€14.9m market cap, or US$17.4m). お知らせ • May 20
Les Hôtels de Paris SA, Annual General Meeting, Jun 26, 2025 Les Hôtels de Paris SA, Annual General Meeting, Jun 26, 2025. Location: normandy hotel, 7 rue de l echelle, paris France Reported Earnings • May 09
Full year 2024 earnings released: €2.38 loss per share (vs €1.51 loss in FY 2023) Full year 2024 results: €2.38 loss per share (further deteriorated from €1.51 loss in FY 2023). Revenue: €43.5m (up 5.1% from FY 2023). Net loss: €17.6m (loss widened 58% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 108 percentage points per year, which is a significant difference in performance. New Risk • Apr 21
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Negative equity (-€42m). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Market cap is less than US$100m (€12.0m market cap, or US$13.6m). Buy Or Sell Opportunity • Apr 02
Now 25% overvalued after recent price rise Over the last 90 days, the stock has risen 17% to €1.36. The fair value is estimated to be €1.08, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 34% over the last 3 years. Earnings per share has declined by 44%. New Risk • Mar 20
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €9.16m (US$9.94m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Negative equity (-€42m). Market cap is less than US$10m (€9.16m market cap, or US$9.94m). Buy Or Sell Opportunity • Mar 18
Now 25% overvalued after recent price rise Over the last 90 days, the stock has risen 13% to €1.35. The fair value is estimated to be €1.08, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 34% over the last 3 years. Earnings per share has declined by 44%. Buy Or Sell Opportunity • Jan 30
Now 33% overvalued after recent price rise Over the last 90 days, the stock has risen 11% to €1.57. The fair value is estimated to be €1.18, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 34% over the last 3 years. Earnings per share has declined by 44%. Buy Or Sell Opportunity • Jan 08
Now 22% overvalued Over the last 90 days, the stock has fallen 2.0% to €1.44. The fair value is estimated to be €1.18, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 34% over the last 3 years. Earnings per share has declined by 44%. Buy Or Sell Opportunity • Nov 21
Now 22% overvalued Over the last 90 days, the stock has fallen 47% to €1.43. The fair value is estimated to be €1.18, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 34% over the last 3 years. Earnings per share has declined by 44%. New Risk • Nov 13
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: €9.31m (US$9.88m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Negative equity (-€42m). Market cap is less than US$10m (€9.31m market cap, or US$9.88m). Buy Or Sell Opportunity • Oct 17
Now 27% overvalued Over the last 90 days, the stock has fallen 44% to €1.50. The fair value is estimated to be €1.18, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 34% over the last 3 years. Earnings per share has declined by 44%. Reported Earnings • Oct 09
First half 2024 earnings released: €1.64 loss per share (vs €0.66 loss in 1H 2023) First half 2024 results: €1.64 loss per share (further deteriorated from €0.66 loss in 1H 2023). Revenue: €19.0m (up 1.1% from 1H 2023). Net loss: €12.1m (loss widened 149% from 1H 2023). Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. New Risk • Apr 23
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.7% average weekly change). Negative equity (-€16m). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€22.0m market cap, or US$23.5m). New Risk • Apr 22
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 9.7% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.7% average weekly change). Negative equity (-€16m). Minor Risk Market cap is less than US$100m (€22.2m market cap, or US$23.6m). Reported Earnings • May 21
Full year 2022 earnings released: €0.64 loss per share (vs €0.53 profit in FY 2021) Full year 2022 results: €0.64 loss per share (down from €0.53 profit in FY 2021). Revenue: €42.5m (up 139% from FY 2021). Net loss: €4.70m (down 219% from profit in FY 2021). Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings. Board Change • Jan 11
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Founder & Chairman Patrick Machefert was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Founder & Chairman Patrick Machefert was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Sep 25
First half 2022 earnings released: €0.64 loss per share (vs €2.12 loss in 1H 2021) First half 2022 results: €0.64 loss per share (improved from €2.12 loss in 1H 2021). Revenue: €17.4m (up 347% from 1H 2021). Net loss: €4.69m (loss narrowed 69% from 1H 2021). Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings. Reported Earnings • Jun 18
Full year 2021 earnings released: EPS: €0.53 (vs €1.95 loss in FY 2020) Full year 2021 results: EPS: €0.53 (up from €1.95 loss in FY 2020). Revenue: €17.8m (up 34% from FY 2020). Net income: €3.95m (up €18.4m from FY 2020). Profit margin: 22% (up from net loss in FY 2020). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings. Board Change • Apr 28
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Founder & Chairman Patrick Machefert was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Dec 27
First half 2021 earnings: Revenues and EPS in line with analyst expectations First half 2021 results: €2.12 loss per share (down from €1.57 loss in 1H 2020). Revenue: €3.91m (down 52% from 1H 2020). Net loss: €15.1m (loss widened 35% from 1H 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings. Reported Earnings • Jun 13
Full year 2020 earnings released: €1.95 loss per share (vs €1.59 loss in FY 2019) The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: €13.2m (down 68% from FY 2019). Net loss: €14.4m (loss widened 27% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings. Is New 90 Day High Low • Dec 04
New 90-day high: €3.20 The company is up 43% from its price of €2.24 on 04 September 2020. The French market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Hospitality industry, which is up 14% over the same period.